Taraxacum officinale inhibits tumor necrosis factor-α production from rat astrocytes

被引:39
作者
Kim, HM [1 ]
Shin, HY
Lim, KH
Ryu, ST
Shin, TY
Chae, HJ
Kim, HR
Lyu, YS
An, NH
Lim, KS
机构
[1] Wonkwang Univ, Coll Pharm, Ctr Oriental Med Sci, Iksan 570749, Chonbuk, South Korea
[2] Wonkwang Univ, Dept Won Buddhism, Iksan 570749, Chonbuk, South Korea
[3] Woosuk Univ, Coll Pharm, Wanju 565701, Chonbuk, South Korea
[4] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan 570749, Chonbuk, South Korea
[5] Wonkwang Univ, Coll Oriental Med, Iksan 570749, Chonbuk, South Korea
关键词
Taraxacum officinale; tumor necrosis factor-alpha; astrocytes; lipopolysaccharide; substance P; interleukin-1;
D O I
10.3109/08923970009026009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Substance P (SP) can stimulate production of tumor necrosis factor-alpha (TNF-alpha) from astrocytes stimulated with lipopolysaccharide (LPS). The objective of the current study was to determine the effect of Taraxacum officinale (TO) on the production of TNF-alpha from primary cultures of rat astrocytes. TO (100 and 1000 mu g/ml) significantly inhibited the TNF-alpha production by astrocytes stimulated with LPS and SP. Interleukin-1 (IL-1) has been shown to elevate TNF-alpha production from LPS-stimulated astrocytes while having no effect on astrocytes in the absence of LPS. We therefore examined whether IL-1 mediated inhibition of TNF-alpha production from primary astrocytes by TO. Treatment of TO (100 and 1000 mu g/ml) to astrocytes stimulated with both LPS and SP decreased IL-1 production significantly. Moreover, the production of TNF-alpha by LPS and SP in astrocytes was progressively inhibited with increasing amount of IL-1 neutralizing antibody. Our results suggest that TO may inhibit TNF-alpha production by inhibiting IL-1 production and that TO has an antiinflammatory activity in the central nervous system.
引用
收藏
页码:519 / 530
页数:12
相关论文
共 24 条
[21]  
ROBBINS DS, 1987, J IMMUNOL, V139, P2593
[22]   IMMUNE ACTIONS IN THE NERVOUS-SYSTEM - A BRIEF REVIEW WITH SPECIAL EMPHASIS ON ALZHEIMERS-DISEASE [J].
ROGERS, J ;
LUBERNAROD, J .
DRUG DEVELOPMENT RESEARCH, 1988, 15 (2-3) :227-235
[23]   IDENTIFICATION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR IN MULTIPLE-SCLEROSIS LESIONS [J].
SELMAJ, K ;
RAINE, CS ;
CANNELLA, B ;
BROSNAN, CF .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :949-954
[24]  
TORRENS Y, 1986, P NATL ACAD SCI USA, V86, P9216